Product NDC: | 16252-599 |
Proprietary Name: | Alendronate Sodium |
Non Proprietary Name: | alendronate sodium |
Active Ingredient(s): | 35 mg/1 & nbsp; alendronate sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16252-599 |
Labeler Name: | Cobalt Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076984 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091023 |
Package NDC: | 16252-599-00 |
Package Description: | 50000 TABLET in 1 PAIL (16252-599-00) |
NDC Code | 16252-599-00 |
Proprietary Name | Alendronate Sodium |
Package Description | 50000 TABLET in 1 PAIL (16252-599-00) |
Product NDC | 16252-599 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | alendronate sodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20091023 |
Marketing Category Name | ANDA |
Labeler Name | Cobalt Laboratories Inc. |
Substance Name | ALENDRONATE SODIUM |
Strength Number | 35 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |